Co-diagnostics, inc. announces corporate rebranding following period of transformative growth and expansion

Salt lake city, sept. 23, 2021 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that following its recent transformative growth, the company is rebranding its image to better reflect its expanded scope, mission, and upcoming expansion into new diagnostics verticals.
CODX Ratings Summary
CODX Quant Ranking